coronavirus Archive — Page 1 of 20
-
June 22, 2021
Combination antibody therapies should retain effectiveness against emerging COVID-19 variants: study
Five monoclonal antibody “cocktails,” including one developed at Vanderbilt University Medical Center (VUMC), are protective in animal studies against several variant strains of COVID-19, according to a report this week in the journal Nature. -
June 17, 2021
Community hospitals shine in vaccine distribution
Vanderbilt University Medical Center’s community hospitals — Vanderbilt Wilson County Hospital (VWCH), Vanderbilt Bedford Hospital and Vanderbilt Tullahoma-Harton Hospital — have risen to the occasion to meet critical vaccination needs across Tennessee. -
June 9, 2021
VUMC’s Alex Jahangir became Nashville’s coronavirus czar, all while never missing a beat in his day job.
“He has served VUMC and our community as the coronavirus czar selflessly and voluntarily while not decreasing by one clinic visit or call night his load or work productivity.” -
May 17, 2021
Marcus Trammell almost died on his way to pick up some pandemic takeout. A year later, his amazing rehab journey continues.
The long way back from the turn lane in front of Dino's Bar and Grill -
May 13, 2021
Research explores how people with traumatic brain injury have adapted to the pandemic
The Department of Hearing and Speech Sciences has conducted research to better understand how individuals with traumatic brain injury (TBI) have adapted to the COVID-19 pandemic. Researchers think the findings may apply to many disability populations in future crises. -
May 12, 2021
Heparin, platelets discouraged as treatment for blood clots after COVID vaccine
Heparin and platelets are discouraged as treatment for patients who develop blood clots in the brain and low platelet counts 6-15 days after receiving Johnson & Johnson’s Janssen COVID-19 vaccine, following a clinical investigation review of 12 U.S. cases conducted by the CDC and institutions including Vanderbilt University Medical Center. -
May 6, 2021
VUMC to lead national study to treat severe COVID complications
The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19.